FOCIS 2023
2023-06-20 08:00 - 2023-06-23 17:00 (America/Vancouver) | MA
FOCIS is THE meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides the unique opportunity for innovative thinking and applying ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study.
Through the FOCIS Annual Meeting, researchers and clinicians share knowledge across traditional disease borders, and identify commonalities between treatments and therapies that are life changing for those affected with immune-mediated diseases. From the introduction of monoclonal antibodies in clinical practice — to recent advances in cancer immunotherapy – the past two decades have been transformational for patients living with immune-mediated diseases.
FOCIS 2023 will take place, in person, June 20-23, 2023, at the Boston Marriott Copley Place.
Your Health and Safety
Your health and safety remain a top priority to FOCIS. The Annual Meeting will be held fully in person, and we are committed to keeping you safe.

Unveiling the Power Within: Tumoroids for Translational IO Drug Discovery & Development
2023-06-21 14:30 - 18:00 (America/Vancouver) | MassBioHub, 700 Technology Square, Cambridge, MA, 02139, United States
Join Nilogen on June 21st from 3:00-6:00pm at the MassBio HUB for an event dedicated to the importance of the tumor microenvironment in translational drug discovery and development. The event will feature a two part plenary session with a presentation session and panel discussion, followed by a networking reception featuring cocktails and hors d’oeuvres.
Agenda:
2:30-3:00pm: Registration & Networking
3:00-3:05pm: Introduction
3:05-3:35pm: Plenary Presentation: “Tumoroids for Translational Drug Discovery & Development”
Presenter: Dr. Soner Altiok, M.D. PhD, Founder & CSO, Nilogen Oncosystems
3:35-4:20pm: Panel Discussion: “Challenges in IO Drug Discovery, Development, and Clinical Translation”
Moderator: Rikhia Chakraborty PhD, VP, R&D & Operations, Nilogen Oncosystems
Panelists:

Johanna Kaufmann PhD, EVP Oncology, Codagenix
Shilpa Demes PhD, Director, Translational Science, Astellas Pharma
Khalid Shah M.S. PhD, Vice Chairman of Research, Neurosurgery, Brigham & Women’s Hospital
Soner Altiok M.D. PhD, Founder & CSO, Nilogen Oncosystems

4:20-6:00pm: Networking Reception

AWIS Boston: DEI Committee Kick-off Social
2023-06-22 17:30 - 18:30 (America/Vancouver) | MA
The AWIS Boston Diversity, Equity & Inclusion Committee invites you to join us for an outdoor social to kick-off our committee and to celebrate Pride Month. We’ll have food, prizes, celebration, and discussion. Everyone is invited to join us whether or not you want to join the committee. We’ll provide some eats and dessert but feel free to bring something to share!

Koch Institute Symposium 2023: Cancer Vaccines
2023-06-23 09:00 - 17:00 (America/Vancouver) | MA
The symposium will feature a keynote talk from Federica Sallusto who is an expert in the field of human cellular immunology.
There will be two sessions which will include renown speakers from academia and industry including Michal Bassani-Sternberg, Tyler Jacks, Charles Swanton, Olivera Finn, Stefani Spranger and Pete DeMuth.
And, we have a special panel discussion with Bob Langer, Paul Burton and Cathy Wu where they will discuss the impact of a vaccine in treatment and progression.

The Investment Climate’s Impact on Biotechs, Tech Transfer & Pipeline
2023-06-26 08:00 - 10:00 UTC | MA
Private biotechs are operating in a fundraising environment where access to capital is limited. This has led to a spike in shutdowns, restructurings, reductions-in-force, and “strategic alternatives” across the industry that one VC investor recently cited. Smaller and more emerging companies may be wondering how to respond, what nontraditional cash, partnering, and business opportunities exist, and how to continue to access funding. For example, “Should we extend our series A or go for a series B?” The market downturn is likewise impacting tech transfer, company spin-out, and the drug discovery pipeline.
Where are innovation and company creation pausing due to tight cash flows and cautious investors? Listen to a panel of speakers who can comment on these questions and offer insights from investor, university, and biotech perspectives.

MERIT Symposium at MassBio
2023-06-27 16:00 - 20:30 UTC | MassBioHub, 700 Technology Square, Cambridge, MA, 02139, United States
Join us at the MassBio Hub in Cambridge on June 27th for an oncology-focused networking and educational event hosted by MERIT. There will be great food and drinks provided along with insightful presentations by industry experts. Don’t miss Dr. Jan Cerny’s, MD, PhD, FACP, talk at 4:30 pm on how pandemic shifts have shaped hematological oncology trials going forward. Dr. Jimmy Belotte, MD, PhD, FACOG, will also be speaking at 5:15 pm to address the opportunities and challenges for diversity in clinical trials. This will be a key opportunity to network with industry peers and oncology KOLs.

Shifting Your Mentality From Discovery to Development
2023-07-10 08:00 - 10:00 (America/Vancouver) | MA
You’ve successfully taken the risks and done the research to turn your abstract thought into something physically real!
As Robert Redford’s character famously said at the end of The Candidate: “What do we do now?” Transitioning from research to development is the goal of every biotech company, but there are also many common misunderstandings and misconceptions about what this shift entails. The costs (it’s expensive) and timelines (it takes a long time), onboarding new team members, successfully doing both the R and the D at the same time, and regulatory aspects of the change are among the things that must be understood and executed.
Approaching this topic through the lens of today’s difficult funding environment and longer time horizons, panelists will bring a breadth of experiences to detail best practices, answer common (and uncommon) questions, cover anticipated business challenges, and likely tell a few horror stories.

4th RNA Editing Summit
2023-07-11 09:00 - 2023-07-13 18:00 (Asia/Dubai) | Hilton Boston Logan Airport, One Hotel Drive, Boston, 02128, United States
The 4th RNA Editing Summit returns as the first and only industry-dedicated forum solely focused on the research and therapeutic potential of RNA editing.
Our 2023 event will welcome first disclosures of exciting data with important learnings being communicated so the field can advance toward the clinic. Expect exclusive data from KOLs on the most recent developments in ADAR, APOBEC, CRISPR-Cas13, Cas7-11, and exon editing. Join 80+ thought leaders from the likes of Wave Life Sciences, ProQR, Shape Therapeutics and Korro Bio to stay ahead of the curve and tap into the therapeutic potential of RNA editing and accelerate clinical validation.
Bringing together a new group of RNA editing senior decision makers, a brand new 6-hour workshop day will delve into the key challenges facing RNA editing, including delivery, manufacturing and proof-of-concept.

The Protein Society 37th Annual Symposium
2023-07-13 09:00 - 2023-07-16 18:00 (America/Halifax) | MA
Connect and share your ideas with hundreds of protein science professionals from around the globe. In addition to our dynamic program, the Symposium will feature numerous networking and career-building opportunities, as well as thematic workshops. Take advantage of discounted registration until May 31, 2023.
Explore your scientific interests and specialties with sessions in 12 specialty tracks and eight award-winning talks designed just for you. Check out our networking opportunities and DEI-focused events to be announced in the spring. Be sure to submit your abstract and apply for a Contributed, Young Investigator Talk and/or Flash Talks included in every session.

Christmas in July — MassBioHub Open House
2023-07-19 16:00 - 18:00 UTC | MassBioHub, 700 Technology Square, Cambridge, MA, 02139, United States
Celebrate Christmas in July at our MassBioHub Open House Reception! Join us as we transform our space into a winter wonderland, complete with holiday decor, music, delectable food, and refreshing drinks to showcase how the Hub is the perfect place for your upcoming 2023 holiday party. Throughout the reception, we will be offering guided tours, allowing you to explore the entire facility and discover its various room configurations. Come check out our offerings and see for yourself what everyone has been raving about!
ABOUT THE HUB
The MassBioHub is our state-of-the-art conference and business center located in the heart of Kendall Square in Cambridge, MA. The Hub is an exclusive benefit for MassBio members, and we offer this exceptional space at below-market rates. Whether you’re planning a small gathering or a larger event, the MassBioHub can accommodate in-person groups of 2 to 150 individuals. Additionally, we provide the option to host hybrid or virtual events, ensuring flexibility to meet your unique needs. For more information and to view our packages, visit massbio.org/hub.

FSHD University – Epic Bio’s FSHD Program
2023-07-20 13:00 - 14:00 (Asia/Dubai) | Online
Epic Bio, a San Francisco based therapeutics company, is developing a gene therapy medicine specifically for FSHD patients. The new product, termed EPI-321, leverages a CRISPR-based platform to precisely find and fix the specific issue in the genome that causes FSHD. It works by restoring a process called methylation to repair the root cause of the disease without altering the DNA sequence. EPI-321 is an AAV-based gene therapy product delivered one time via intravenous infusion.

2023 MassBio Diversity, Equity, and Inclusion Conference
2023-07-20 13:00 - 17:30 UTC | MA
This year’s MassBio Diversity Equity and Inclusion (DEI) Conference will shine a light on the topic of health equity and how clinical trial diversity is a meaningful and achievable step toward the equitable delivery of health care.
Keynote speakers and panelists will examine aspects of health equity including attaining trial diversity, selecting diverse suppliers, and earning patient and community trust. Participants will also leave with actionable takeaways and extensive resources after breaking into small groups for an interactive workshop. There will be ample time for participants to expand their networks, share personal experiences, and build the relationships that will lead to progress toward mutual DEI goals.

3rd mRNA-Based Therapeutics Summit
2023-07-26 13:00 - 2023-07-28 22:00 UTC | MA
With over 800 mRNA drugs now in development and the industry accelerating towards clinical success, the mRNA–Based Therapeutics Summit returns for its 3rd year as the industry’s largest networking opportunity to date, showcasing exclusive new data from the movers and shakers in the field.
Ensure your whole team stays ahead of the curve by joining 400+ key mRNA opinion leaders from Moderna, BioNTech, CureVac, Pfizer and Sanofi including regulatory insights from the FDA and EMA at the world’s only end-to-end meeting focused on the next generation of mRNA-based therapeutics and vaccines.

Expect 100+ world-class speakers from large pharma, innovative biotechs, and academia, with 3 days of jam-packed content with 5 dedicated tracks (discovery, translation, clinical development, chemistry, manufacturing and controls (CMC) and logistics) deep–dive focus and workshop days, C–Level Fireside Discussions and more, enabling you to overcome industry hurdles including optimized dosing, targeted delivery, safety and scalability to achieve regulatory success in infectious and rare diseases, cancer and beyond!

18th SCCT Annual Scientific Meeting
2023-07-27 12:00 - 2023-07-30 13:00 (Asia/Dubai) | MA
SCCT2023 is the premier meeting focused on cardiovascular CT. SCCT2023 is designed to engage physicians, trainees, technologists, and healthcare professionals in a complete overview of the cardiovascular CT field. Planned sessions are targeted for all levels – new practitioners and experienced providers alike. Sessions also range from general overviews to state-of-the-art research and expert discussions.
Join us for sessions on structural heart disease, congenital heart disease, guidelines and trials, AI/Machine learning, technical aspects of cardiac CT, coronary artery disease, valvular heart disease, debates, and games, and early career topics.

BioC2023: the Bioconductor Annual Conference
2023-08-02 08:00 - 2023-08-04 16:00 (America/Vancouver) | Dana-Farber Cancer Institute & Online
We are incredibly excited that Bioc2023 the annual Bioconductor meeting will be in Boston at the Dana-Farber Cancer Institute from August 2-4. It is a hybrid meeting to enable maximum outreach to our global community.
Speakers include:

JJ Allaire (Founder and CEO of RStudio, Posit PBC)
Heng Li (Associate Professor, Dana-Farber Cancer Institute, Harvard Medical School)
Beth Cimini (Senior Group Leader, Broad Institute of MIT & Harvard)
Jeffrey Moffitt (Assistant Professor, Harvard Medical School and Boston Children’s Hospital)
Sam Lent (Senior Computational Biologist at Freenome)

Connect with talented R/Bioconductor users & developers, data scientists, biostatisticians, and bioinformaticians at #Bioc2023

The Annual Chemistry and Pharmacology of Drug Abuse Conference
2023-08-03 07:30 - 2023-08-04 13:00 (America/Vancouver) | MA
The Chemistry and Pharmacology of Drug Abuse (CPDA) Conference brings together top medicinal chemists and pharmacologists to present their recent findings. These scientists approach the challenge of avoiding drug addiction and of treating it when it does occur. By investigating alternative molecular receptors and novel pathways of information transfer, they seek non-addictive pain therapies, possibly ones that do not require morphine. codeine or derivatives thereof.

Immuno-Oncology Summit 2023
2023-08-07 07:30 - 2023-08-09 15:45 (America/Vancouver) | MA
Over the past 11 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the next wave of biotherapeutics, advances in technologies, and the valuable exchange of high-quality research from all disciplines of immuno-oncology. CHI’s IO Summit provides access to a comprehensive 3-day program for participants to evaluate bi- or multi-specific biotherapeutics, explore the latest developments in existing and emerging cellular therapies, develop predictive preclinical models for translational strategies and appraise AI and computational tools for the discovery of new targets, target classes, and combinations to overcome resistance. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, so, together, we continue to align as a formidable force against cancer. Additionally, the progressive venue provides extensive networking and collaborative opportunities to enable teams to focus on their goals as they advance our understanding of the immune system to provide next generation immunotherapies to all patients.

The 15th Annual Bioprocessing Summit
2023-08-14 08:00 - 2023-08-17 16:25 (Asia/Dubai) | MA
Celebrating its fifteenth year, The Bioprocessing Summit is a premier global forum for industry leaders to share the latest developments in bioprocess R&D, scale-up, quality and analytics. This year’s programming comprises more in-depth content than ever before, showcasing 8 topic-focused streams, 14 conference tracks, interactive sessions, panel discussions, training seminars, research posters, and so much more.
Learn from over 300 top researchers and network with more than 1,500 global participants.
Reserve your spot now to lock in advance registration savings!

The mRNA Conference 2023
2023-08-28 08:00 - 2023-08-29 18:00 (Asia/Dubai) | MA
Welcome to The mRNA Conference 2023, where global pharmaceutical and biotech companies will meet with world-leading industry experts in Boston, Massachusetts, to explore the latest innovations in mRNA-based therapeutics and vaccines for infectious diseases, oncology, CAR-T cell therapies, and beyond.
Recent vaccine success has put mRNA technology into the spotlight with increasingly growing potential for applications in immunotherapy, personalised medicine, and clinical treatments of genetic, infectious, and chronic diseases. The mRNA conference will focus on developing mRNA vaccines and therapies from early research to commercialization and clinical applications.
This exclusive event will showcase invaluable insights into differentiated drug platforms through RNA modification and delivery systems, next-generation mRNA therapeutics, formulations, clinical development, and supply chain and logistics.

8th International Conference on Accelerating Biopharmaceutical Development
2023-09-06 - 2023-09-08 | Royal Sonesta Boston, 40 Edwin H Land Boulevard, Cambridge, MA, 02142, United States
This conference series brings together senior thought leaders from across multiple disciplines to discuss strategies, technologies and capabilities that accelerate biopharmaceutical development. The theme of the AccBio 2023 is “Applying enduring lessons from the pandemic, including accelerated development of a broad range of vaccines and therapeutics”.

Hypertension Scientific Sessions 2023
2023-09-07 07:30 - 2023-09-10 11:30 UTC | MA
Join us at one of the most important medical meetings about hypertension in the world, with experts in the fields of hypertension and its relationship to cardiac and kidney disease, stroke, obesity and genetics. Oral and poster presentations, cross-disciplinary connections, sessions for early-career and trainees, clinical science and practice, primary care programming: there’s a lot here for you!

RegSci Forum “An Inflection Point for High-Quality Diagnostic Tests in Oncology”
2023-09-12 12:00 - 13:00 (America/Vancouver) | Online
Speaker:
Dr. Brian Alexander, CEO Foundation Medicine
About the talk:
The evolution of precision cancer care—the practice of matching the right patient to the right treatment at the right time—has advanced care significantly in recent years. We have made tremendous progress in fighting cancer using insights from our increased understanding of the genomic mutations underlying the more than 100 different types of cancer. But precision cancer care can only be as good as the quality of the tests used to guide diagnosis and treatment. Today, we are at an inflection point where we have an opportunity to prioritize the development and availability of high-quality tests so patients and physicians can receive accurate and reliable information allowing them to confidently inform a diagnosis, disease progression and treatment options. Regulatory reforms that are fundamentally flawed and disincentivize the development of high-quality tests are not in the best interest of patients.

The BioProcess International Conference & Exhibition
2023-09-18 - 2023-09-21 | Boston Convention and Exhibition Center (BCEC), 415 Summer St., Boston, MA, 02210, United States
The BPI US 2023 scientific agenda includes 200+ of the industry’s top scientists to present the latest updates on how to improve efficiencies across all phases of biopharmaceutical development and production.

Our BPI 2023 agenda includes 8 conference tracks covering novel science across all phases of bioprocessing for biologics, cell & gene therapies. Your registration provides access to the presentations across all 8 tracks, allowing you to create an agenda tailored specifically for your needs. Your conference pass provides on-demand access to the main conference presentation recordings for a full 12 months after the in-person event concludes.

BioTech Week
2023-09-18 09:30 - 2023-09-21 15:35 (America/Vancouver) | Boston Convention and Exhibition Center (BCEC), 415 Summer St., Boston, MA, 02210, United States
Be a part of this unique experience spanning the drug development value chain, giving you access to the most innovative scientific minds and business leaders in Boston and around the world.
Biotech Week Boston is a series of co-located events that each have their own scientific agendas and registration fees. Attendees of these co-located events come together during shared networking receptions to facilitate cross-event networking.

BIOMEDevice Boston 2023
2023-09-20 10:00 - 2023-09-21 16:00 (America/Vancouver) | Boston Convention and Exhibition Center (BCEC), 415 Summer St., Boston, MA, 02210, United States
From digital health to surgical robotics, BIOMEDevice is the starting point for the discovery of progressive solutions to challenges and impactful products. It brings together engineers, business leaders, disruptive companies and innovative thinkers from the top start-ups and medical device OEMs together to inspire and collaborate on the next life-changing medical device. Our community comes together in Boston, September 20-21, 2023, the number three medtech hub in the United States to share new innovations, educate each other on what’s new in the industry, collaborate on new ideas, and partner to move the industry forward. What are you waiting for join the BIOMEDevice community today!

CANARY
2023-09-20 19:30 - 21:30 (America/Vancouver) | MA
Dr. Alex Rivest once studied the brain circuits underlying episodic memory formation Massachusetts Institute of Technology (MIT). Now the Boston native has taken to the big screen to change the way the public sees scientists.
“We’ve all just lived through a moment when the world stopped because society could not grapple with science. This is a problem for an enterprise that is so fundamental to our understanding of where we belong in the universe and how to navigate a better, more sustainable future,” Dr. Rivest tells Science In Boston.
“I set out to create more heroes in science and elevate more scientists by telling some of the most amazing stories of curiosity, overcoming seemingly impossible odds, and bravery beyond what any of us can imagine. When I left academia, I set out to change the way science is seen in the media.”
CANARY is coming to the Boston Common Theater for one night only. Support Dr. Rivest next week on September 20th at 7:30 pm.

Cambridge Science Festival
2023-09-25 - 2023-10-01 | MA
Cambridge Science Festival, the first of its kind in the United States, is a city-wide celebration showcasing the leading edge in science, technology, engineering, art, and math (STEAM).
Comprising hundreds of events, workshops, lectures, demonstrations, multidisciplinary collaborations, family-friendly exhibitions and interactive experiences, CSF is a STEAM-themed extravaganza highlighting Cambridge’s diverse innovative community.
Check out the full festival guide for more information about these events and hundreds more…

AACR Special Conference In Cancer Research: Pancreatic Cancer
2023-09-27 06:00 - 2023-09-30 00:15 (America/Vancouver) | MA
The ninth AACR Special Conference on Pancreatic Cancer will address the latest developments in pancreatic cancer research; spanning basic, translational and clinical research areas. The program will focus on incorporating numerous talks from submitted abstracts to highlight the advancements and diversity of the pancreatic cancer research field. Special sessions that present cutting-edge research, career development opportunities, and discuss controversies in the field will be exciting for both young and established investigators alike. Make plans now to participate in this stimulating conference.

BIES: Bill Lotter, Dana-Farber Cancer Institute and Harvard Medical School
2023-09-27 13:30 - 15:00 (America/Vancouver) | Online
Hosted by Harvard Office of Technology Development and the HMS Dept. of Biomedical Informatics.
Open to all, in person at Harvard Medical School, Gordon Hall Room 106, The Waterhouse Room or online via Zoom.
In-person networking with food and drink from 4:30-5:00pm, followed by presentation by speaker at 5:00pm, broadcasted online via Zoom.
Featured speaker:
Bill Lotter, Ph.D., is an Assistant Professor at the Dana-Farber Cancer Institute and Harvard Medical School. He was previously the CTO & Co-Founder of DeepHealth Inc. (acquired by RadNet Inc.), where he led the development and large-scale deployment of FDA-cleared products that use AI to assist in mammogram interpretation. He has also held positions as an algorithmic trader for DRW Trading and a consultant for the Baltimore Ravens. In this talk, he will share his journey in applying AI/ML across various domains, lessons learned, and perspectives when considering different career options.
Location:
We are pleased to return, for another in-person Salon and intend to host this talk as a hybrid event. All are welcome to join us at Gordon Hall, Room 106, The Waterhouse Room, at Harvard Medical School in Boston! For those unable to attend in-person, we truly welcome and invite you to join us on Zoom (access the Zoom registration link via Eventbrite’s “Online Event Page” after registering with Eventbrite).However you plan to join us, please do register here with Eventbrite.
This Entrepreneurs Salon will be hosted by Isaac Kohane, Chair, Department of Biomedical Informatics, Harvard Medical School.

AACR Special Conference
2023-09-27 18:00 - 2023-09-30 12:15 UTC | MA
